Clinically high-risk breast cancer displays markedly discordant molecular risk predictions between the MammaPrint and EndoPredict tests
暂无分享,去创建一个
F. Fitzal | F. Moinfar | M. Knauer | F. Offner | O. Tsybrovskyy | S. Jahn | Z. Jasarevic | A. Bösl | Christine Gruber-Rossipal | R. Helfgott | M. Balić